Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1950251
Max Phase: Preclinical
Molecular Formula: C9H8N2O
Molecular Weight: 160.18
Molecule Type: Small molecule
Associated Items:
ID: ALA1950251
Max Phase: Preclinical
Molecular Formula: C9H8N2O
Molecular Weight: 160.18
Molecule Type: Small molecule
Associated Items:
Synonyms (1): N-(Cyanomethyl)Benzamide
Synonyms from Alternative Forms(1):
Canonical SMILES: N#CCNC(=O)c1ccccc1
Standard InChI: InChI=1S/C9H8N2O/c10-6-7-11-9(12)8-4-2-1-3-5-8/h1-5H,7H2,(H,11,12)
Standard InChI Key: LPKZSPQPPSEVSX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 160.18 | Molecular Weight (Monoisotopic): 160.0637 | AlogP: 0.94 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.89 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 0.58 | CX LogD: 0.58 |
Aromatic Rings: 1 | Heavy Atoms: 12 | QED Weighted: 0.65 | Np Likeness Score: -1.64 |
1. Bhattacharya AK, Rana KC.. (2011) Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors., 19 (23): [PMID:22019466] [10.1016/j.bmc.2011.09.058] |
2. Jöst C, Nitsche C, Scholz T, Roux L, Klein CD.. (2014) Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments., 57 (18): [PMID:25148591] [10.1021/jm5006918] |
3. Schirmeister T, Schmitz J, Jung S, Schmenger T, Krauth-Siegel RL, Gütschow M.. (2017) Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei., 27 (1): [PMID:27890381] [10.1016/j.bmcl.2016.11.036] |
Source(1):